Please login or sign up to post and edit reviews.
Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
Publisher |
WIRED
Media Type |
audio
Categories Via RSS |
Science
Publication Date |
Nov 14, 2023
Episode Duration |
00:06:49

The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.

Read this story here.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review